production
/viewbook/list/all/?page=4480
/
/static/
None
Not Available
Not available
Not available
Not available
Not Available
Not available
Not available
0495563293
Not Available
Not available
Not available
Not available
Not Available
Not available
Not available
Not available
Not Available
Not available
Not available
Not available
Not Available
Not available
Not available
Not available
Not Available
Informa Healthcare
Not available
1420073540
Examines harmonization of the US Federal Food, Drug, and Cosmetic Act with international regulations as they apply to human drug and device development,... research, manufacturing, and marketing. The Second Edition focuses on the new drug approval process, cGMPs, GCPs, quality system compliance, and corresponding documentation requirements. Written in a jargon-free style, it draws information from a wide range of resources. It demystifies the inner workings of the FDA and facilitates an understanding of how it operates with respect to compliance and product approval. FDA Regulatory Affairs: provides a blueprint to the FDA and drug, biologic, and medical device development offers current, real-time information in a simple and concise format contains a chapter highlighting the new drug application (NDA) process discusses FDA inspection processes and enforcement options includes contributions from experts at companies such as Millennium and Genzyme, leading CRO’s such as PAREXEL and the Biologics Consulting Group, and the FDA Three all-new chapters cover: clinical trial exemptions advisory committees provisions for fast track
Not Available
Food and Drug Law Inst
Not available
1935065424
Between 1939 and 1945, the Nazis murdered six million Jews in the Holocaust and looted Jewish assets currently valued at between $230 billion and $320... billion. As Hitler's power grew, many Jewish families and businesses took advantage of the promise of secrecy and protection and deposited their funds in Swiss banks. For over half of a century, these funds remained in Swiss banks, protected by a veil of Swiss banking secrecy, concealed by coordinated bank obfuscation. In 1996 and 1997, Holocaust survivors' class actions lawsuits against leading Swiss banking institutions were assigned to Chief Judge Edward R. Korman, who has written an introduction to this volume. In 2000, Judge Korman approved an historic settlement of $1.25 billion. Judge Korman's opinions were affirmed on seven occasions by the Second Circuit. Judge Jose Cabranes, who has written a preface to the volume, was a member of each appellate panel. A Final Accounting introduces, organizes, explains, and evaluates this complex litigation, frames the case in a larger historical and jurisprudential context and examines the limits of court awards as an instrument to rectify horrific wrongs.
Not Available
Not available
Not available
Not available
Not Available
Not available
Not available
Not available
Not Available
Not available
Not available
Not available
Not Available
Not available
Not available
Not available
Not Available
Not available
Not available
Not available
Not Available
Not available
Not available
Not available
Not Available
Not available
Not available
Not available
'